Arax Advisory Partners’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$616K	Sell	2,458 -2,121	-46%	-$528K	0.02%	570
2025 Q4	$1.26M	Sell	4,579 -18,063	-80%	-$4.94M	0.04%	337
2025 Q3	$5.94M	Buy	22,642 +19,876	+719%	+$4.83M	0.09%	194
2025 Q2	$605K	Sell	2,766 -23	-0.8%	-$4.92K	0.03%	352
2025 Q1	$624K	Sell	2,789 -576	-17%	-$159K	0.04%	258
2024 Q4	$1.1M	Sell	3,365 -120	-3%	-$37.8K	0.07%	166
2024 Q3	$1.05M	Buy	3,485 +1,132	+48%	+$347K	0.09%	116
2024 Q2	$775K	Buy	2,353 +238	+11%	+$84.1K	0.08%	134
2024 Q1	$837K	Buy	2,115 +832	+65%	+$308K	0.09%	116
2023 Q4	$452K	Buy	1,283 +64	+5%	+$22.6K	0.05%	169
2023 Q3	$458K	Buy	1,219 +786	+182%	+$304K	0.06%	150
2023 Q2	$166K	Hold	433	–	–	0.02%	270
2023 Q1	$150K	Buy	433 +12	+3%	+$3.51K	0.02%	280
2022 Q4	$99.1K	Buy	+421	New	+$99.8K	0.01%	334
2022 Q3	–	Sell	-12	Closed	-$4K	–	1270
2022 Q2	$4K	Sell	12 -9	-43%	-$2.93K	﹤0.01%	861
2022 Q1	$9K	Hold	21	–	–	﹤0.01%	676
2021 Q4	$10K	Hold	21	–	–	﹤0.01%	669
2021 Q3	$9K	Sell	21 -32	-60%	-$13.5K	﹤0.01%	669
2021 Q2	$19K	Buy	+53	New	+$17.5K	﹤0.01%	589